Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report

Diagn Pathol. 2013 Nov 25:8:192. doi: 10.1186/1746-1596-8-192.

Abstract

Clear cell sarcoma is a rare cancer primarily of tendons, fascia, and aponeuroses that can be difficult to discern from primary cutaneous malignant melanoma. The two cancers share several histological markers, with most cases of both cancers staining positively for S-100, HMB-45, and melanin. Primary therapy of both cancers involves wide local excision, but while systemic therapy has proven benefit for malignant melanoma, it has not been established for clear cell sarcoma.We report the case of a 58 year old woman with a large, ulcerated, fungating mass on her left lower leg. Frozen section of the mass showed a malignant epithelioid and spindle cell tumor confined to the subcutaneous tissue. A provisional diagnosis of soft-tissue sarcoma was made. Through in-depth study of initial biopsy with immunohistochemistry for S-100, HMB-45, MART-1, and MITF, along with karyotyping and FISH analysis for EWS gene rearrangement, the diagnosis of amelanotic malignant melanoma was confirmed. The patient then underwent systemic treatment with ipilimumab upon recurrence with good response.

Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1989338475107348.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Diagnosis, Differential
  • Female
  • Humans
  • Ipilimumab
  • MART-1 Antigen / metabolism
  • Melanoma / diagnosis*
  • Melanoma / drug therapy
  • Melanoma / metabolism
  • Microphthalmia-Associated Transcription Factor / metabolism
  • Middle Aged
  • Proto-Oncogene Proteins B-raf*
  • Sarcoma, Clear Cell / diagnosis*
  • Sarcoma, Clear Cell / metabolism
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / metabolism
  • Soft Tissue Neoplasms / diagnosis*
  • Soft Tissue Neoplasms / metabolism
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Ipilimumab
  • MART-1 Antigen
  • Microphthalmia-Associated Transcription Factor
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf